Prophylactic vaccines are potent activators of monocyte-derived dendritic cells and drive effective anti-tumor responses in melanoma patients at the cost of toxicity.
about
Immune-related Adverse Events of Dendritic Cell Vaccination Correlate With Immunologic and Clinical Outcome in Stage III and IV Melanoma Patients.Adjuvant dendritic cell vaccination induces tumor-specific immune responses in the majority of stage III melanoma patients.Ipilimumab administered to metastatic melanoma patients who progressed after dendritic cell vaccination.In Vivo Expansion of Melanoma-Specific T Cells Using Microneedle Arrays Coated with Immune-Polyelectrolyte Multilayers.Dendritic cell vaccination in melanoma patients: From promising results to future perspectivesSubstrate stiffness influences phenotype and function of human antigen-presenting dendritic cells.Recent Successes and Future Directions in Immunotherapy of Cutaneous Melanoma.mRNA vaccines - a new era in vaccinology.Local Immunotherapy of Cancer: Innovative Approaches to Harnessing Tumor-Specific Immune Responses.Dendritic Cell Cancer Therapy: Vaccinating the Right Patient at the Right Time
P2860
Q36992766-3788E0DF-AC37-4F22-B9A5-58FBE0306D2EQ37222157-8BCB769E-4A26-408B-B2CE-E91C45F4B810Q37224609-2CB4A765-C741-45C0-BF1A-B33BCF3FD509Q37682217-40E9B06C-A4A3-46DF-AFC0-0B46A1A3D1E0Q38850950-7BA11870-7B45-4C50-AA41-2C3975590A6DQ47114789-1DD03E88-4E66-4288-86A2-3E52BB88B930Q47134263-42D6B3C1-A296-4CF4-B1E4-17385D265D45Q47736893-2DF9A73A-4874-4C43-8F39-AFFB39F662BAQ52353493-7632575D-B77F-4EB6-9013-638E8E48FCA7Q57486475-A8E19391-F975-4F08-BFC9-FE9C1A17CE9D
P2860
Prophylactic vaccines are potent activators of monocyte-derived dendritic cells and drive effective anti-tumor responses in melanoma patients at the cost of toxicity.
description
2016 nî lūn-bûn
@nan
2016 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Prophylactic vaccines are pote ...... tients at the cost of toxicity
@nl
Prophylactic vaccines are pote ...... ients at the cost of toxicity.
@ast
Prophylactic vaccines are pote ...... ients at the cost of toxicity.
@en
type
label
Prophylactic vaccines are pote ...... tients at the cost of toxicity
@nl
Prophylactic vaccines are pote ...... ients at the cost of toxicity.
@ast
Prophylactic vaccines are pote ...... ients at the cost of toxicity.
@en
prefLabel
Prophylactic vaccines are pote ...... tients at the cost of toxicity
@nl
Prophylactic vaccines are pote ...... ients at the cost of toxicity.
@ast
Prophylactic vaccines are pote ...... ients at the cost of toxicity.
@en
P2093
P2860
P50
P3181
P1476
Prophylactic vaccines are pote ...... tients at the cost of toxicity
@en
P2093
Annemiek J de Boer
Chantal A A van der Graaf
Cornelis J A Punt
Erik H J G Aarntzen
Gerty Schreibelt
Gosse J Adema
Jeanette M Pots
Mandy W M M van de Rakt
Michel A M Olde Nordkamp
Michelle M van Rossum
P2860
P2888
P304
P3181
P356
10.1007/S00262-016-1796-7
P407
P577
2016-02-10T00:00:00Z
P5875
P6179
1033466257